Records containing: HIV Prevention
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-10-14Phase 1 Study of the Safety, Toxicity, Pharmacokinetics, Pharmacodynamics and Luminal Distribution of Single-dose DuoGel Through Rectal Administration
-
CLINICAL_TRIALS study record update · 2019-09-06Empowering With PrEP Cluster-Randomized Controlled Trial: A Social Media Based Peer-Led Intervention for HIV Prevention
-
CLINICAL_TRIALS study record update · 2019-07-11VRC 605: A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered Intravenously or Subcutaneously to Healthy Adults
-
CLINICAL_TRIALS study record update · 2019-07-08Demonstration Project on the Feasibility to Implement a Pre-Exposure Oral Prophylaxis Program in Men Who Have Sex With Other Men and Transgender Women at Risk of Acquiring HIV
-
CLINICAL_TRIALS study record update · 2019-04-18ClinicalTrials.gov study NCT02958813
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-08-22ImPrEP Sub-study - HIV Self-Testing to Increase Combination Prevention Demand in the ImPrEP Project: an Adaptative Randomized Trial
-
CLINICAL_TRIALS study record update · 2018-07-18Finding the Right Tenofovir/Emtricitabine Regimen for Pre-Exposure Prophylaxis (PrEP) in Transgender Women
-
CLINICAL_TRIALS study record update · 2018-05-22SEPA III: The Effectiveness Trial
-
CLINICAL_TRIALS study record update · 2018-05-22A Phase 1, Randomized, Double-Blind Pharmacokinetic and Safety Study of Dapivirine/Levonorgestrel Vaginal Rings
-
CLINICAL_TRIALS study record update · 2018-01-26Changing the STI Care Model to Reduce Genital Inflammation and HIV Risk in South African Women
-
CLINICAL_TRIALS study record update · 2018-01-26Development and Testing of a Jamaican Mother-daughter HIV Risk-reduction Program
-
CLINICAL_TRIALS study record update · 2017-12-18A Pilot Project to Operationalize the Prevention Strategy of Post Exposure Prophylaxis Following Sexual Exposure to HIV in Combination With Educational Programming and Behavioral Risk Reduction Strategies in Los Angeles County
-
CLINICAL_TRIALS study record update · 2017-09-20A Pilot Demonstration Project to Operationalize Pre-exposure Prophylaxis as Part of Combination HIV Prevention Among Men Who Have Sex With Men (MSM) and Transgender Women in Los Angeles County
-
CLINICAL_TRIALS study record update · 2017-09-07Safety and Acceptability Study of Non-Surgical Male Circumcision Device for Adult Male Population When Removing the Foreskin Shortly After Placement of Device Performed at Lusaka and Livingstone, Zambia
-
CLINICAL_TRIALS study record update · 2017-07-19Four-Arm RCT of Brief MI vs. Couples-Based HIV/STI Prevention in South Africa
-
CLINICAL_TRIALS study record update · 2017-02-13Formative Research for an HIV Videogame for Young Black Women
-
CLINICAL_TRIALS study record update · 2016-10-04Integrated Mental Health Treatment & HIV Prevention for Court-Involved Youth
-
CLINICAL_TRIALS study record update · 2015-08-28A Two-site, Phase 1, Partially-blinded, Placebo-controlled Safety, Acceptability and Pharmacokinetic Trial of Topical, Vaginally-formulated Tenofovir 1% Gel Applied Rectally Compared With Oral 300 mg Tenofovir Disoproxil Fumarate in HIV-1 Seronegative Adults
-
CLINICAL_TRIALS study record update · 2015-05-22In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products
-
CLINICAL_TRIALS study record update · 2015-05-01Phase I Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females
-
CLINICAL_TRIALS study record update · 2015-04-17A Phase III, Multi-Centre, Randomized Controlled Trial to Assess the Safety and Effectiveness of the Vaginal Microbicide 1% Tenofovir Gel in the Prevention of Human Immunodeficiency Virus Type 1 Infection in Women, and to Examine Effects of the Microbicide on the Incidence of Herpes Simplex Virus Type 2 Infection
-
CLINICAL_TRIALS study record update · 2015-04-10Assessing the Effect of Contraception and the Menstrual Cycle on Pharmacokinetics, Pharmacodynamics, and Vaginal Safety in Tenofovir Vaginal Gel Users
-
CLINICAL_TRIALS study record update · 2015-04-10Influence of Female Reproductive Cycle and Menopause on Cervicovaginal Tissue Susceptibility to HIV-1 Infections and Tenofovir 1% Gel Activity
-
CLINICAL_TRIALS study record update · 2015-04-10EVALUATION OF A USER-FILLED, PAPER APPLICATOR FOR DELIVERY OF TENOFOVIR 1% GEL AMONG WOMEN IN RURAL KWAZULU-NATAL, SOUTH AFRICA
-
CLINICAL_TRIALS study record update · 2014-11-03One-arm, Open Label, Phase I (Out of 3 Phases), Pilot Study to Verify the Safety of PrePex™ Device for Screen Failure Subjects (Men With Narrow Foreskin and Phimosis) for Adult Male Circumcision, Performed by Physicians, in a Male Population That is Scheduled to Undergo Circumcision in an Effort to Prevent the Spread of HIV.